BioVersys AG is a privately-held biopharmaceutical company headquartered in Switzerland. We are committed to delivering long term value to patients and investors by developing new therapies to combat antimicrobial drug resistance, a major unmet medical need.

To find out more about current investment opportunities in BioVersys please contact us.